Alaunos Therapeutics, Inc.: which funds bought and sold

Institutions that bought and sold Alaunos Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.

Between March 31, 2026 and June 30, 2026, 12 institutions that filed 13F reports for both quarters added to or opened positions in Alaunos Therapeutics, and 7 cut or closed them. Together they sold a net 36K shares, −28.2% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 9,488 shares (−44.4%); index fund managers were net sellers of 3,204 shares (−4.4%). 6 opened a new position and 4 sold out entirely.

Bought, Q2 2026 12 institutions, 6 of them new holders Sold, Q2 2026 7 institutions, 4 of them sold out

Net change, all compared −36K shares (−28.2%)

Net change, active managers −9,488 shares (−44.4%), 1 bought, 1 sold

Buyers versus sellers

institutions compared, 33

12 bought 14 7 sold

Active managers and hedge funds 1 bought · 1 sold · −9,488

Index fund managers 0 bought · 1 sold · −3,204

Other institutions 11 bought · 5 sold · −23K

Biggest buyers

by change in shares held

Biggest buyers
Institution	Change in shares	Shares June 30, 2026	Value
Citadel Advisors LLC Hedge fund	+1,351 +12.8%	12K	$26,826
Arax Advisory Partners	+1,216 New position	1,216	$2,749
Wells Fargo & Company	+198 +104.2%	388	$877
Royal Bank Of Canada	+190 +102.7%	375	$1,000
Morgan Stanley	+183 +28.0%	836	$1,889
Bokf, Na	+66 New position	66	$149
Axiom Investment Management LLC	+46 New position	46	$104
Tower Research Capital LLC (TRC)	+38 +2.4%	1,621	$3,663
Steward Partners Investment Advisory, LLC	+20 +21.7%	112	$253
Barclays PLC	+15 New position	15	$34
West Paces Advisors Inc.	+10 New position	10	$23
Ifg Advisory, LLC	+6 New position	6	$14

Biggest sellers

by change in shares held

Biggest sellers
Institution	Change in shares	Shares June 30, 2026	Value
HRT Financial LP	−13K Sold out	0	—
Two Sigma Investments, LP Hedge fund	−11K Sold out	0	—
Xtx Topco Ltd	−10K Sold out	0	—
Geode Capital Management, LLC Index funds	−3,204 −14.2%	19K	$43,753
UBS Group AG	−1,282 −56.4%	992	$2,242
Osaic Holdings, Inc.	−48 −2.7%	1,731	$3,907
Citigroup Inc	−1 Sold out	0	—

Biggest sellers, active managers and hedge funds
Institution	Change in shares	Shares June 30, 2026	Value
Two Sigma Investments, LP Hedge fund	−11K Sold out	0	—

New positions

largest by value

Institution	Shares	Value June 30, 2026
Arax Advisory Partners	1,216	$2,749
Bokf, Na	66	$149
Axiom Investment Management LLC	46	$104
Barclays PLC	15	$34
West Paces Advisors Inc.	10	$23
Ifg Advisory, LLC	6	$14

Sold out

largest by value

Institution	Shares	Value March 31, 2026
HRT Financial LP	13K	$38,000
Two Sigma Investments, LPHedge fund	11K	$31,000
Xtx Topco Ltd	10K	$29,098
Citigroup Inc	1	$3

Who holds the shares

13F holdings at June 30, 2026

Institutions reporting: 29
Ten largest holders: 98.0%
Index fund managers: 77.7%
Active managers and hedge funds: 13.1%

Buying and selling by type of institution, March 31, 2026 to June 30, 2026
Type	Bought	Sold	New	Sold out	Net change in shares	Net %
Active managers and hedge funds	1	1	0	1	−9,488	−44.4%
Index fund managers	0	1	0	0	−3,204	−4.4%
Other institutions	11	5	6	3	−23K	−73.5%

Active managers and hedge funds: a list we maintain of about 400 well-known stock-picking firms and hedge funds, matched by SEC registration number (CIK) and checked against the filer names each quarter. Index fund managers: the large index houses, such as BlackRock, Vanguard, State Street, Geode and Northern Trust. Every other filer (banks, brokers, wealth managers, pension funds, insurers and firms not on the list) counts as another institution. A firm that files under several SEC registrations appears once for each.

What these filings can and cannot tell you

Form 13F lists the long positions in US-listed shares held by investment managers with more than $100 million in such holdings. Managers file it up to 45 days after each quarter ends, so this page shows what funds held at the end of each quarter, not what they are doing now: a position may have changed since. Short positions, most derivatives and smaller managers are not included, and a cut can mean a fund lost clients or rebalanced rather than a view on Alaunos Therapeutics.

Only managers that filed a holdings report for both quarters are compared (33 here). 2 other holders are left out: first-time or late filers, firms that changed their SEC registration, and filings that withheld positions under confidential treatment, any of which would otherwise look like a new position or a sale. Figures are as reported by each manager in the SEC's quarterly 13F data sets; option positions are excluded.

← Back to Alaunos Therapeutics, Inc. · Insiders · Politicians